Resonance Health LtdASX: RHT

Half Year Results

· Issued by Resonance Health Ltd

Filed with ASX · · 4 pages · English

Summary by 6ix AI

The company reported a notable increase in revenue and a positive operating cash flow, alongside advancements in its clinical trial services and software-as-a-medical-device offerings. Resonance Health's CEO emphasized the strong execution across its business units and the ongoing expansion of its operations. The filing includes an operational update and outlook for the second half of the fiscal year, maintaining previous revenue and EBITDA guidance.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Resonance Health Ltd on 6ix

In the deck

Story so far

Earlier from Resonance Health

Later from Resonance Health

All Resonance Health news releases